CCR Clinical Trials at NIH: Clinical Research: Search for Clinical Trials at NIH

The NCI Center for Cancer Research (CCR) conducts more than 150 cancer clinical trials at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. Cancer clinical trials that take place at the NIH Clinical Center are open to patients with cancer, regardless of where they live in the United States.

Go to Search Page

There are 15 clinical trials at NIH that match your search criteria

Cancer by type/disease: Brain Tumor

Trial and Protocol Number Brain Tumor	Principal Investigator	Referral Contact
Phase II
A Phase II Trial of Sunitinib in the Treatment of Recurrrent Malignant Gliomas NCI-08-C-0168	Teri Kreisl 301-402-3423	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
A Phase II Trial of Tandutinib in Combination With Bevacizumab for Patients With Recurrent High-Grade Gliomas NCI-08-C-0101	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
A Phase II Trial of Enzastaurin (LY317615) in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas NCI-08-C-0015	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
A Phase II Trial of Bevacizumab and Irinotecan for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 NCI-06-C-0250	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas NCI-06-C-0112	Kevin Camphausen 301-496-5457	Sharon L. Smith 301-496-5457 smiths@mail.nih.gov
Phase II Trial of Bevacizumab for Patients With Recurrent High-Grade Glioma NCI-06-C-0064	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
A Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas NCI-05-C-0137	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
Phase I/II
Phase I/II Study of ZD6474 in Patients With Recurrent High-Grade or Progressive Low-Grade Gliomas NCI-06-C-0063	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
Phase I
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas NCI-07-C-0053	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
No Phase
An Exploratory Study of Biologic and Pathophysiologic Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors NCI-06-C-0219	Katherine E. Warren 301-496-4256	Robyn Bent 301-496-8009 rbent@mail.nih.gov
Comparative Trial of Pediatric CNS Tumor Activity as Assessed by PET Imaging and Proton Magnetic Resonance Spectroscopy Imaging (MRSI) NCI-03-C-0278	Katherine E. Warren 301-496-4256	Robyn Bent 301-496-8009 rbent@mail.nih.gov
A Prospective National Study to Molecularly and Genetically Characterize Human Gliomas: The Glioma Molecular Diagnostic Initiative NCI-02-C-0140	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov
Evaluation of the Natural History of Patients With Tumors of the Central Nervous System NCI-01-C-0070	Howard A. Fine 301-402-6298	Charisse Garcia 301-402-6298 garciacr@mail.nih.gov

Trial and Protocol Number AIDS Related Cancers	Principal Investigator	Referral Contact
Phase II
AIDS-Related Primary Central Nervous System Lymphoma: A Phase II Pilot Study of High-Dose Intravenous Methotrexate With Rituximab Leucovorin Rescue and Highly Active Antiretroviral Therapy NCI-06-C-0051	Robert Yarchoan 301-496-8959	Karen Aleman 301-496-8959 1-800-243-2732 ext. 4 (Toll Free) alemank@mail.nih.gov

Trial and Protocol Number Solid Tumor	Principal Investigator	Referral Contact
Phase I
A Phase I Trial and Pharmacokinetic Study of Trabectedin (YONDELIS^®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors NCI-07-C-0054	Elizabeth Fox 301-402-6641	Pediatric Oncology 1-877-624-4878 (Toll free)

For additional studies that may be appropriate for your disease type, please search under Solid Tumor.